3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Prostatic Neoplasms
5
Ovarian Neoplasms
4
Breast Neoplasms
4
Pancreatic Neoplasms
3
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Triple Negative Breast Neoplasms
2
Neoplastic Syndromes, Hereditary
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Sarcoma
1
Rectal Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Fanconi Anemia, Complementation Group D1
1
Cytopenia
1
Congenital Bone Marrow Failure Syndromes
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Intraductal, Noninfiltrating
1
Cancer Risk Syndrome
1
Breast Neoplasms, Male
1
Bone Marrow Failure Disorders
1
Advanced Malignant Neoplasm
1
Interventions
Blood Specimen Collection
11
Radiosurgery
7
Sentinel Lymph Node Biopsy
5
Early Intervention, Educational
5
Surveys and Questionnaires
4
Standard of Care
4
Practice Guidelines as Topic
4
Methods
4
Indocyanine Green
4
Educational Status
4
X-Rays
3
Surgical Procedures, Operative
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Immunotherapy
3
Cognitive Behavioral Therapy
3
Biopsy
3
pembrolizumab
2
montanide ISA 51
2
aldesleukin
2
Tomography, X-Ray Computed
2
Tomography, Emission-Computed
2
Specimen Handling
2
Radiotherapy
2
Radiation
2
Positron-Emission Tomography
2
Palliative Care
2
Observation
2
Interviews as Topic
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Melanoma
×
Genetic Counseling
×
Clear all
NCT05225428
2026-05-22
VERDI
Dana-Farber Cancer Institute
Phase NA
Recruiting
1,020 enrolled